Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria
- 1 March 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (3) , 426-431
- https://doi.org/10.1128/aac.34.3.426
Abstract
Erythromycin binds to a single site on the bacterial 50S ribosomal subunit and perturbs protein synthesis. However, erythromycin contains desosamine and thus exists in both protonated (greater than 96%) and neutral (less than 4%) forms at physiological pH because of the pKa of the dimethylamino group. We therefore examined the relative roles of both forms in binding to ribosomes isolated from two species each of gram-positive and gram-negative bacteria. We developed a system to directly measure the forward (association) rate constant of formation of the macrolide-ribosome complex, and we have measured both the forward and reverse (dissociation) rate constants as a function of pH. Forward rate constants and binding affinity did not correlate with pH when the interaction of erythromycin with ribosomes from both gram-positive and gram-negative bacteria was examined, demonstrating that the protonated form of this macrolide binds to ribosomes. Conversely, the neutral form of macrolide cannot be the sole binding species and appears to bind with the same kinetics as the protonated form. Forward rate constants were 3- to 4-fold greater at physiological pH, and binding affinity calculated from rate constants was 5- to 10-fold greater than previously estimated. Similar results were obtained with azithromycin, a novel 15-membered macrolide that contains an additional tertiary amine in the macrolide ring. Ribosome- and macrolide-specific kinetic parameters were demonstrated at neutral pH and may be related to the potency of the two macrolides against gram-positive and gram-negative bacteria.This publication has 18 references indexed in Scilit:
- Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growthAntimicrobial Agents and Chemotherapy, 1989
- Uptake of erythromycin by McCoy and HEp2 cells: its dependence on cellular pH gradientsJournal of Antimicrobial Chemotherapy, 1988
- Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987
- A SURVEY OF X-RAY DIFFRACTION STUDIES OF ENZYME-OTHER MOLECULE INTERACTIONS AS POSSIBLE MODELS FOR RECEPTOR SITESAnnals of the New York Academy of Sciences, 1981
- Interaction between the erythromycin and chloramphenicol binding sites on the Escherichia coli ribosomeBiochemistry, 1977
- The distance between two functionally significant regions of the 50 S Escherichia coli ribosome: the erythromycin binding site and proteinsJournal of Molecular Biology, 1976
- Binding of [ 14 C]Erythromycin to Escherichia coli RibosomesAntimicrobial Agents and Chemotherapy, 1974
- Determination of Rate Constants for In Vitro Three-Compartment Transfer Using a Two-Phase SystemJournal of Pharmaceutical Sciences, 1971
- STUDIES ON THE ANTIBIOTICS FROM STREPTOMYCES SPINICHROMOGENES VAR. KUJIMYCETICUS. VThe Journal of Antibiotics, 1970
- The intermolecular complex of erythromycin and ribosomeJournal of Molecular Biology, 1969